KeyVexKeyVex
Sign in
KeyVex › Disclosures › Executive-branch trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Rahul Gupta, N Director, Office of National Drug Control Policy, Office of National Drug Control Policy, disclosed 1 transaction

· Executive-branch trades · U.S. Office of Government Ethics (Form 278-T)

2023-02-09 · purchaseKimberly-Clark Corp. — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerself
sourceOGE_278T
tickerKMB
notifiedfalse
filing idoge-278t-rahul-gupta-2023-03-06-1
amount max15000
amount min1001
asset nameKimberly-Clark Corp.
filer nameRahul Gupta
filer typeappointee
report urlhttps://extapps2.oge.gov/201/Presiden.nsf/PAS+Index/614C6E3A6954FFAA85258987002EC090/$FILE/Rahul-Gupta-03.06.2023-278T.pdf
scraped at2026-06-02T23:33:32.275Z
filing date2023-03-06
amount range$1,001 - $15,000
filer positionN Director, Office of National Drug Control Policy, Office of National Drug Control Policy
transaction date2023-02-09
transaction typepurchase

Original filing document